Peter J. Graham

CIK: 0001235635

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ADCT

ADC Therapeutics SA

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

ADCT
ADC Therapeutics SA
Jun 30, 2026
Award(A)
Direct
221.1K shares-
ADCT
ADC Therapeutics SA
Feb 13, 2026
Award(A)
Direct
294.8K shares at avg. $3.99$1.2M
ADCT
ADC Therapeutics SA
Feb 13, 2026
Tax Payment(F)
Direct
33.3K shares at avg. $3.99$133K
ADCT
ADC Therapeutics SA
Dec 6, 2025
Tax Payment(F)
Direct
49.5K shares at avg. $3.29$163K
ADCT
ADC Therapeutics SA
Feb 13, 2025
Award(A)
Direct
220K shares at avg. $1.61$354K
ADCT
ADC Therapeutics SA
Dec 6, 2024
Tax Payment(F)
Direct
41.5K shares at avg. $3.13$130K

		Type	Shares	Price		Ownership
Jun 30, 2026	ADCT ADC Therapeutics SA	Award(A)	221,100	-	$0	Direct
Feb 13, 2026	ADCT ADC Therapeutics SA	Award(A)	294,800	$3.99	$1,176,252	Direct
Feb 13, 2026	ADCT ADC Therapeutics SA	Tax Payment(F)	33,294	$3.99	$132,843	Direct
Dec 6, 2025	ADCT ADC Therapeutics SA	Tax Payment(F)	49,508	$3.29	$162,881	Direct
Feb 13, 2025	ADCT ADC Therapeutics SA	Award(A)	220,000	$1.61	$354,200	Direct
Dec 6, 2024	ADCT ADC Therapeutics SA	Tax Payment(F)	41,458	$3.13	$129,764	Direct

1-6 of 6 transactions

About GRAHAM PETER J

GRAHAM PETER J (SEC CIK 0001235635) files insider reports with the SEC as Chief Legal Officer of ADC Therapeutics SA (ADCT).

Signal8 holds 5 ownership filings by GRAHAM PETER J, all Form 4s, filed between Dec 9, 2024 and Jul 2, 2026. Those filings report 6 transactions, from Dec 6, 2024 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on GRAHAM PETER J's filings is in NEW PROVIDENCE, NJ.

Recent filings by GRAHAM PETER J

Jun 30, 2026: Grant or award of ADCT shares (Form 4, code A).
Feb 13, 2026: Grant or award of ADCT shares (Form 4, code A).
Feb 13, 2026: Tax withholding of ADCT shares (Form 4, code F).
Dec 6, 2025: Tax withholding of ADCT shares (Form 4, code F).
Feb 13, 2025: Grant or award of ADCT shares (Form 4, code A).

Other insiders filing for ADC Therapeutics SA (ADCT)

Zaki Mohamed, Chief Medical Officer
Carmona Jose, Chief Financial Officer
MALLIK AMEET, Chief Executive Officer
Azelby Robert, Director
Squarer Ron, Director
Sandor Victor, Director

How to read Form 4 transaction codes